Rabiatou Sangare

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer-Associated Thrombosis: The Observational ROADMAP-CAT Study

Konstantinos Syrigos, Dimitra Grapsa, Rabiatou Sangare et al. · The Oncologist · 2018 · 49 citations · Full text

Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study

Despina Fotiou, Theodoros Ν. Sergentanis, Loula Papageorgiou et al. · Blood Cancer Journal · 2018 · 34 citations · Full text

Impact of blood hypercoagulability on in vitro fertilization outcomes: a prospective longitudinal observational study

Grigoris Gerotziafas, Patrick Van Dreden, Emmanuelle Mathieu d’Argent et al. · Thrombosis Journal · 2017 · 25 citations · Full text